Submitted by nenadkesic@gmail.com on Fri, 04/20/2018 - 07:11
Interview with Kimberly L Blackwell, MD
Interview with Joyce O’Shaughnessy, MD
Track 1:
Case: A 51-year-old woman with ER-positive, HER2-negative lobular BC treated with 5 years of tamoxifen presents 1 year later with a local recurrence
Track 2:
Case: A 33-year-old pregnant woman with ER/PR-positive, HER2-positive locally advanced BC
Track 3:
Update of a combined analysis of the TEXT and SOFT trials: Adjuvant exemestane with ovarian function suppression (OFS) versus tamoxifen and OFS for premenopausal women with HR-positive early BC
Track 4:
Factors influencing use and duration of adjuvant pertuzumab
Track 5:
Risks of anti-HER2 therapy for pregnant patients
Track 6:
Clinical utility of postadjuvant neratinib
Track 7:
Case: A 42-year-old woman with a 1.8-cm, Grade III, ER/PR-negative, HER2-positive, node-negative BC
Track 8:
Case: A 50-year-old postmenopausal woman with a 1.3-cm, Grade II, strongly ER/PR-positive, “HER2-positive” invasive lobular carcinoma
Track 9:
Case: A 40-year-old woman with a 3.7-cm, Grade II, ER/PR-positive, HER2-negative suspected ductal carcinoma with 1 of 17 positive nodes declines adjuvant chemotherapy
Track 10:
Evolution of circulating tumor DNA analyses as a diagnostic tool
Track 11:
Case: A 45-year-old woman with triple-negative IDC and 2 large palpable lymph nodes achieves a pathologic complete response to neoadjuvant AC→T
Track 12:
Perspective on the potential addition of carboplatin to neoadjuvant chemotherapy for TNBC
Track 13:
Therapeutic options for patients with ER-positive, HER2-negative, BRCA2 germline mutation-positive BC and residual disease after neoadjuvant chemotherapy and surgery
Track 14:
Reliability and concordance of Ki-67 testing
Track 15:
Viewpoint on the clinical utility of the 21- and 70-gene assays for patients with 1 to 3 positive lymph nodes
FACULTY
Kimberly L Blackwell, MD
Professor of Medicine
Director, Breast Cancer Program
Duke Cancer Institute
Durham, North Carolina
Joyce O’Shaughnessy, MD
Chair Breast Cancer Research Program Baylor Charles A Sammons Cancer Center Celebrating Women Chair in Breast Cancer Research
Texas Oncology
US Oncology
Dallas, Texas
EDITOR
Neil Love, MD
Research To Practice
Miami, Florida